Predominance of females with oesophageal cancer in Gezira, Central Sudan.

Arab J Gastroenterol

Department of Medicine, Faculty of Medicine, University of Gezira, Wad Medani, Sudan.

Published: December 2012

Background: The majority of oesophageal cancer cases occur in developing countries. Globally males predominate.

Objective: This study aims to review the clinical aspects of oesophageal carcinoma in Sudanese patients referred to endoscopy in Gezira, Central Sudan.

Patients & Method: Data were collected from patients who underwent endoscopy during the period from 2005 to 2007 at The Gezira Centre for Gastroenterology Endoscopies and Laparoscopic Surgery. Demographic and clinical data including; sex, age, locality of residence, clinical presentation, tumour site and morphology were collected and analysed.

Results: Seven hundred and two patients were consecutively referred to our centre for endoscopy. Seventy-three out of 702 patients (9.6%) referred for endoscopy proved to have oesophageal cancer. Fifty-five out of 73 patients (75.3%) were females generating a male to female ratio of 1:3.3. The mean age of females was 52.75±11.66years and that of males was 66.11±9.52. Sixteen (21.9%) patients came from the Managil; 14 (19.2%) from Hasaheesa and Rufaa; 14 (19.2%) from Blue Nile; 10 (13.7%) from Wadmedani (Central Sudan) and 19 (26%) from Elfaw and Kassala. In most cases (75.3%), the tumours were located in the middle third of the oesophagus. 79.5% of the tumours were squamous cell type.

Conclusion: Patients referred for endoscopy to The Gezira Centre for Gastroenterology, Endoscopies and Laparoscopic Surgery in Gezira revealed a greater proportion of women than of men diagnosed with the disease (1:3.3). More studies are needed to investigate the epidemiology of this disease and to identify the reason for the apparent gender uneven manifestation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajg.2012.06.012DOI Listing

Publication Analysis

Top Keywords

oesophageal cancer
12
referred endoscopy
12
gezira central
8
central sudan
8
patients referred
8
endoscopy gezira
8
gezira centre
8
centre gastroenterology
8
gastroenterology endoscopies
8
endoscopies laparoscopic
8

Similar Publications

Objective: This study systematically evaluated the efficacy of programmed death 1 (PD-1) inhibitors combined with chemotherapy for advanced esophageal cancer (EC).

Methods: PubMed, Embase, Web of Science, Scopus, and Cochrane Library were searched to identify related randomized controlled trials (RCTs).

Results: Seven RCTs involving 4,363 participants were included.

View Article and Find Full Text PDF

Background: Gastric cancer (GC) is one of the leading contributors to global malignancies incidence and mortality worldwide. Advanced GC had a relatively poor prognosis. The emerging of targeted therapy improved the survival and prognosis of GC patients.

View Article and Find Full Text PDF

Triple-negative breast cancer (TNBC) remains a significant global health challenge, emphasizing the need for precise identification of patients with specific therapeutic targets and those at high risk of metastasis. This study aimed to identify novel therapeutic targets for personalized treatment of TNBC patients by elucidating their roles in cell cycle regulation. Using weighted gene co-expression network analysis (WGCNA), we identified 83 hub genes by integrating gene expression profiles with clinical pathological grades.

View Article and Find Full Text PDF

Global, regional, and national burden of esophageal cancer using the 2019 global burden of disease study.

Sci Rep

January 2025

Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.

Esophageal cancer, with its aggressive nature and high mortality, poses diverse epidemiological challenges worldwide. Over the past three decades, esophageal cancer has exhibited a substantial global burden, marked by a significant increase in absolute numbers, contrasting with a decline in age-standardized metrics. Prevalence nearly doubled, reaching 0.

View Article and Find Full Text PDF

Activation of the p38 mitogen-activated protein kinase (MAPK) pathways is vital in regulating cell growth, differentiation, apoptosis, and stress response, significantly affecting tumorigenesis and cancer progression. We developed a bioinformatic technique to construct an interactome network-based molecular pathways for genes of interest and quantify their activation levels using high-throughput gene expression data. This study is focused on the p38α, p38β, p38γ, and p38δ kinases, examining their activation levels (PALs) based on transcriptomic data and their associations with survival and drug responsiveness across various cancer types.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!